|
|
Resonance Health Limited - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Resonance Health Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Resonance Health Limited. The Group's principal activities are developing and commercializing of technologies for the quantitative analysis of radiological images. Its core product is FerriScan, a liver diagnostic technology used for the measurement of iron overload in the liver. It uses a computer software to analyze data obtained through magnetic resonance imaging (MRI). The Group operates within Australia and the United States of America.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|